Collegium Pharmaceutical, Inc. (NASDAQ:COLL) showcases a Return on Invested Capital (ROIC) of 10.34%, significantly outperforming its Weighted Average Cost of Capital (WACC) of 5.18%.Amphastar Pharmaceuticals and Syndax Pharmaceuticals demonstrate lower efficiency in capital utilization compared to Collegium, with Amphastar barely generating returns above its cost of capital.Ironwood Pharmaceuticals exhibits the highest efficiency with a ROIC of 62.21% and a WACC of 6.21%, indicating exceptional capital man ...

Core Insights - Immunocore Holdings plc is a biotechnology company focused on developing T cell receptor-based therapeutics, currently in the development stage with high R&D costs before achieving profitability [1] - The company's Return on Invested Capital (ROIC) is -1.74%, and its Weighted Average Cost of Capital (WACC) is 7.98%, indicating it is not generating returns above its cost of capital [2][6] - The ROIC to WACC ratio for Immunocore is -0.22, which is better than some peers, suggesting a relatively better potential for capital efficiency improvement [2][6] Peer Comparison - Vor Biopharma Inc. has a ROIC of -232.79% and a WACC of 9.67%, resulting in a ROIC to WACC ratio of -24.09 [3] - Cullinan Therapeutics, Inc. reports a ROIC of -53.35% and a WACC of 4.55, leading to a ROIC to WACC ratio of -11.72 [3] - Sana Biotechnology, Inc. has a ROIC of -57.87% and a WACC of 12.06, resulting in a ROIC to WACC ratio of -4.80 [3] - Design Therapeutics, Inc. stands out with a ROIC of -38.71% and a WACC of 11.33, achieving the highest ROIC to WACC ratio of -3.42, indicating a closer potential to achieving positive returns [4] Industry Context - All companies analyzed, including Immunocore, are operating with negative ROIC, which is typical for early-stage biotechnology firms [5][6] - Investors should consider ROIC and WACC metrics alongside other factors such as pipeline progress, market potential, and financial health when evaluating investment opportunities in the biotechnology sector [5]

Shift4 Payments (NYSE:FOUR) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsChristopher Cruz - CFODominic Ball - VP of Equity ResearchTaylor Lauber - CEOThomas McCrohan - Head of Investor RelationsWill Nance - VPConference Call ParticipantsDan Dolev - Managing Director and Senior Fintech Equity Research AnalystDan Perlin - Managing Director and Senior Equity AnalystDarrin Peller - Managing Director and Senior AnalystTimothy Chiodo - Managing Director and Lead Equity Research AnalystO ...

Core Insights - Stock Yards Bancorp, Inc. (SYBT) operates in the competitive U.S. banking sector, providing a range of services including personal and business banking, wealth management, and investment services [1][6] Financial Performance - SYBT's Return on Invested Capital (ROIC) is 7.91%, while its Weighted Average Cost of Capital (WACC) is 13.52%, resulting in a ROIC to WACC ratio of 0.58, indicating inefficient capital utilization [2][6] - In comparison, Lakeland Financial Corporation (LKFN) has a ROIC of 10.40% and a WACC of 13.82%, leading to a ROIC to WACC ratio of 0.75, which also suggests challenges in capital efficiency [3] - Republic Bancorp, Inc. (RBCAA) shows a ROIC of 9.04% and a WACC of 8.50%, resulting in a ROIC to WACC ratio of 1.06, indicating effective capital utilization and better growth prospects compared to SYBT [4] - TriCo Bancshares (TCBK) and S&T Bancorp, Inc. (STBA) have negative ROIC to WACC ratios of -0.54 and -0.20, respectively, indicating struggles with capital efficiency [5][6]

Core Insights - Planet Fitness, Inc. is a prominent fitness center operator in the U.S., known for its affordable gym memberships and "Judgement Free Zone" philosophy, which fosters an inclusive environment for all fitness levels [1] Financial Performance - Planet Fitness has a Return on Invested Capital (ROIC) of 10.12% and a Weighted Average Cost of Capital (WACC) of 9.02%, resulting in a ROIC to WACC ratio of 1.12, indicating effective capital utilization [2][6] - Compared to peers, Planet Fitness's capital efficiency is moderate, with Wingstop Inc. achieving a ROIC of 21.54% and a WACC of 10.60%, leading to a higher ROIC to WACC ratio of 2.03 [3] - Match Group, Inc. has the highest ROIC to WACC ratio of 2.42, with a ROIC of 18.50% and a WACC of 7.66%, indicating superior efficiency in generating returns relative to its cost of capital [4] - Other competitors like Five Below, Inc. and Live Nation Entertainment, Inc. have lower ROIC to WACC ratios of 0.90 and 0.99, respectively, while Dave & Buster's Entertainment, Inc. shows a negative ratio of -0.04, indicating inefficiency [5]

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) demonstrates a strong Return on Invested Capital (ROIC) of 20.84% compared to its Weighted Average Cost of Capital (WACC) of 9.83%, indicating efficient capital utilization.ACADIA Pharmaceuticals leads with the highest ROIC to WACC ratio among peers, suggesting superior efficiency and growth potential.Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is a biopharmaceutical company that focuses on developing medicines that treat intractable diseases by silencing the ...

Rimini Street, Inc. (NASDAQ:RMNI) is a leading provider of enterprise software support services, offering third-party support for major software brands like Oracle and SAP. This approach enables clients to significantly reduce their maintenance costs. In the competitive landscape of software support services, Rimini Street distinguishes itself through its remarkable financial performance and efficient capital utilization.Key Insights:Rimini Street's Return on Invested Capital (ROIC) is 49.18%, substantially ...

LegalZoom's Return on Invested Capital (ROIC) is 6.34%, indicating challenges in generating returns that exceed its cost of capital.Xometry and other peers also struggle with capital efficiency, with Xometry showing a negative ROIC to WACC ratio.Clear Secure, Inc. (YOU) demonstrates superior capital utilization with a ROIC of 33.80% and a ROIC to WACC ratio of 3.72.LegalZoom.com, Inc. (NASDAQ:LZ) is a company that provides online legal solutions for small businesses and individuals. It offers services such ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has a Return on Invested Capital (ROIC) of -22.45%, indicating it is not generating sufficient returns to cover its cost of capital.Xencor, Inc. (XNCR) also has a negative ROIC but performs slightly better than Enanta in terms of its ROIC to WACC ratio.PTC Therapeutics, Inc. (PTCT) stands out with a positive ROIC of 37.39%, showcasing efficient use of capital to generate returns above its cost of capital.Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) is a biotechnology ...

Core Insights - Dolby Laboratories, Inc. is recognized for its innovative sound technologies and competes with companies like NETGEAR, Inc., Morningstar, Inc., Copart, Inc., and MSC Industrial Direct Co., Inc. in financial performance and capital efficiency [1] Financial Performance - Dolby has a Return on Invested Capital (ROIC) of 8.76% and a Weighted Average Cost of Capital (WACC) of 7.63%, resulting in a ROIC to WACC ratio of 1.15, indicating efficient capital utilization [2][6] - Copart, Inc. leads the group with a ROIC to WACC ratio of 1.65, showcasing superior efficiency in generating returns over its cost of capital [3][6] - Morningstar, Inc. and MSC Industrial Direct Co., Inc. have ROIC to WACC ratios of 1.37 and 1.61, respectively, highlighting their strong capital efficiency [4] - NETGEAR, Inc. has a negative ROIC to WACC ratio of -0.69, indicating inefficiency in generating returns above its cost of capital [5][6]